Table 2 Assessment of the quality of the included studies using the Joanna Briggs Institute’s (JBI) scale
From: Cell therapy for retinal degenerative disorders: a systematic review and three-level meta-analysis
Year | Author | Criteria and Corresponding Score | Overall | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
#1 | #2 | #3 | #4 | #5 | #6 | #7 | #8 | #9 | |||
2015 | Song | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | NA | 8 |
2015 | Park | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 0 | 7 |
2016 | Limoli | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 8 |
2017 | Cotrim | 1 | 1 | 1 | 0 | 1 | 0 | 1 | 1 | 0 | 6 |
2017 | Kumar | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 9 |
2018 | Da Cruz | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 8 |
2018 | Kashani | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | NA | 7 |
2018 | Liu | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | NA | 8 |
2018 | Oner | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | NA | 8 |
2019 | Heier | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | NA | 7 |
2020 | Cotrim | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 9 |
2020 | Nittala | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 8 |
2020 | Sung | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | NA | 7 |
2021 | Kashani | 1 | 0 | 1 | 0 | 1 | 1 | 1 | 1 | NA | 6 |
2021 | Li | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 8 |
2021 | Tuekprakhon | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 9 |
2021 | Wiacek | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 9 |
2023 | Brant Fernandes | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 8 |